Longitudinal associations between 4-hydroxynonenal and depression in coronary artery disease patients

Michael Rosen1, Parco Chan2, Mahwesh Saleem1

  • 1Neuropsychopharmacology Research Group, Sunnybrook Health Sciences Centre, FG-08, 2075 Bayview Avenue, Toronto, Ontario M4N 3M5, Canada.

Psychiatry Research
|September 30, 2018
PubMed

Insights

Depression in coronary artery disease (CAD) patients may be linked to oxidative stress. A study found that 4-hydroxy-2-nonenal (4-HNE) levels decreased less in depressed CAD patients, suggesting it may mark depression progression.

Area of Science:

  • Cardiology
  • Psychiatry
  • Biochemistry

Background:

  • Depressive symptoms in coronary artery disease (CAD) patients can reduce cardiac rehabilitation (CR) benefits.
  • Oxidative stress is a potential mechanism contributing to depression.

Purpose of the Study:

  • To investigate the longitudinal relationship between lipid peroxidation markers and depression in CAD patients undergoing CR.
  • To identify potential biomarkers for depression in this population.

Main Methods:

  • Measured serum levels of lipid hydroperoxides (LPH), 4-hydroxy-2-nonenal (4-HNE), and 8-isoprostane (8-ISO) in 120 CAD patients.
  • Diagnosed depression at baseline using the Structured Clinical Interview for DSM Axis I Disorders - Depression Module (SCID).
  • Assessed depressive symptom severity using the Center for Epidemiological Studies Depression Scale (CES-D) over 6 months of CR.

Main Results:

  • Serum 4-HNE levels decreased less in depressed CAD patients compared to non-depressed patients.
  • A reduction in serum 4-HNE concentrations was significantly associated with a decrease in CES-D scores over the 6-month CR period.

Conclusions:

  • 4-hydroxy-2-nonenal (4-HNE) may serve as a significant marker for depressive symptoms in patients with coronary artery disease.
  • 4-HNE may play a role in the progression of depression within the CAD patient population.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.1K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
471
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
273
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
383
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
696
Longitudinal Research02:20

Longitudinal Research

Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
13.3K